Clinical trials: Stuttering, Developmental
Persistent Developmental Stuttering
EXPRESS: Examining Pagoclone for Persistent Developmental Stuttering Study
The objective of the study is to determine the effects of pagoclone on the symptoms of Persistent Developmental Stuttering, using a flexible dosing titration regimen on persistent developmental stuttering in patients 18 to 65…
- Trial name
- NCT00216255
- Testing
- Pagoclone
- Where
- 16 sites in United States
- Volunteers
- 120 people
- Sponsor
- Endo USA Inc., a Keenova Therapeutics Company